These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 11408921)
1. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. Zhang H; Sun XF Int J Oncol; 2001 Jul; 19(1):49-52. PubMed ID: 11408921 [TBL] [Abstract][Full Text] [Related]
2. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Sun XF Clin Cancer Res; 2002 Jan; 8(1):165-70. PubMed ID: 11801554 [TBL] [Abstract][Full Text] [Related]
3. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706 [TBL] [Abstract][Full Text] [Related]
4. SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer. Zhang H; Widegren E; Wang DW; Sun XF Tumour Biol; 2011 Dec; 32(6):1225-31. PubMed ID: 21887554 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients. Toumi AA; El Hadj Oel A; Ben Mahmoud LK; Ben Hmida Ael M; Chaar I; Gharbi L; Mzabi S; Bouraoui S Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):128-36. PubMed ID: 19956069 [TBL] [Abstract][Full Text] [Related]
6. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression. Martín R; Nieto S; Santamaría L Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Thomas GV; Szigeti K; Murphy M; Draetta G; Pagano M; Loda M Am J Pathol; 1998 Sep; 153(3):681-7. PubMed ID: 9736017 [TBL] [Abstract][Full Text] [Related]
8. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery. Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; Romano C; Vollaro M; Agostini B; Pignatelli C; De Vita F Dis Colon Rectum; 2004 Nov; 47(11):1904-14. PubMed ID: 15622584 [TBL] [Abstract][Full Text] [Related]
10. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741 [TBL] [Abstract][Full Text] [Related]
11. Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells. Zhang H; Schneider J; Rosdahl I Int J Oncol; 2002 Jul; 21(1):43-8. PubMed ID: 12063548 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Sun XF; Carstensen JM; Zhang H; Stål O; Wingren S; Hatschek T; Nordenskjöld B Lancet; 1992 Dec; 340(8832):1369-73. PubMed ID: 1360088 [TBL] [Abstract][Full Text] [Related]
13. Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas. Lim YJ; Kim YH; Ahn GH; Chun HK; Jang WY; Lee JH; Son HJ; Rhee PL; Kim JJ; Paik SW; Yoo BC; Rhee JC Korean J Gastroenterol; 2004 Dec; 44(6):314-20. PubMed ID: 15665575 [TBL] [Abstract][Full Text] [Related]
14. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis. Hoos A; Nissan A; Stojadinovic A; Shia J; Hedvat CV; Leung DH; Paty PB; Klimstra D; Cordon-Cardo C; Wong WD Clin Cancer Res; 2002 Dec; 8(12):3841-9. PubMed ID: 12473598 [TBL] [Abstract][Full Text] [Related]
15. Expression of second class of KIP protein p57KIP2 in human colorectal carcinoma. Noura S; Yamamoto H; Sekimoto M; Takemasa I; Miyake Y; Ikenaga M; Matsuura N; Monden M Int J Oncol; 2001 Jul; 19(1):39-47. PubMed ID: 11408920 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma. Noguchi T; Kikuchi R; Ono K; Takeno S; Moriyama H; Uchida Y Oncol Rep; 2003; 10(4):827-31. PubMed ID: 12792730 [TBL] [Abstract][Full Text] [Related]
19. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1. Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival. Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]